You are not logged in
You need to be a member to print this page.
Sign up for free membership, or log in.
Find out more about our membership benefits
NICE try but a long way to go in heart failure
September 2004 Volume 11, Issue 5 Br J Cardiol 2004;11:339-41
Authors:
Andrew Owen
The pharmacological treatment of patients with chronic
heart failure has changed dramatically over the past 25
years. This change began with the demonstration of
the beneficial effects of the combination of hydralazine and
isosorbide dinitrate in the V-HeFT-I (Veterans Administration
Co-operative Study) trial.
In the near future, you will need to be a registered user to view full articles
Already a member? Login now
Comments
There are currently no comments for this article - leave a comment
You must be logged in to post a comment.
Not yet a member? Register now for free.
